Medirom Healthcare Technologies Reports Record Sales Per Customer and 77.8% Repeat Rate in December 2025

Reuters02-02
Medirom Healthcare Technologies Reports Record Sales Per Customer and 77.8% Repeat Rate in December 2025

MEDIROM Healthcare Technologies Inc. reported its key performance indicators for December 2025. The company served 70,499 customers during the month, with sales per customer reaching JPY 7,926, which is approximately JPY 3,120 higher than the Japanese industry average of JPY 4,806. The customer repeat ratio was 77.8%, an increase of 0.2 percentage points from the previous year. For salons located in public bath houses, the repeat ratio was 58.9%. In its health tech business, the company’s Lav® app had a cumulative user count of 12,398 as of December 2025, and Medirom had contracts with 102 corporate insurance associations. Starting with the December 2025 release, the company will transition from monthly to quarterly KPI disclosures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-008788), on February 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment